Analysts expect that Henry Schein, Inc. (NASDAQ:HSIC) will post earnings per share of $0.83 for the current quarter, Zacks reports. Seven analysts have provided estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $0.78 and the highest estimate coming in at $0.88. Henry Schein posted earnings of $0.94 per share during the same quarter last year, which would suggest a negative year over year growth rate of 11.7%. The firm is expected to issue its next earnings report on Tuesday, May 4th.
According to Zacks, analysts expect that Henry Schein will report full-year earnings of $3.68 per share for the current fiscal year, with EPS estimates ranging from $3.57 to $3.85. For the next financial year, analysts forecast that the firm will report earnings of $4.02 per share, with EPS estimates ranging from $3.80 to $4.20. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that follow Henry Schein.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 16th. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.01. Henry Schein had a net margin of 6.14% and a return on equity of 11.60%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $2.86 billion. During the same quarter last year, the company posted $0.97 earnings per share.
A number of equities analysts have weighed in on the stock. TheStreet lowered shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Thursday, February 25th. Robert W. Baird upgraded shares of Henry Schein from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $70.00 to $79.00 in a research report on Monday, January 4th. Piper Sandler reiterated an “overweight” rating and set a $83.00 target price on shares of Henry Schein in a research report on Monday, February 8th. Finally, Barrington Research increased their target price on shares of Henry Schein from $72.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, February 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $67.71.
NASDAQ:HSIC traded up $0.56 on Wednesday, reaching $69.95. 25,177 shares of the company’s stock were exchanged, compared to its average volume of 1,047,536. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.49 and a quick ratio of 0.92. The firm has a market cap of $9.95 billion, a price-to-earnings ratio of 17.09, a P/E/G ratio of 3.12 and a beta of 0.86. Henry Schein has a 52 week low of $49.83 and a 52 week high of $74.89. The stock has a fifty day simple moving average of $65.99 and a 200-day simple moving average of $65.86.
In other news, Director Deborah Derby acquired 760 shares of the business’s stock in a transaction dated Wednesday, February 24th. The stock was bought at an average cost of $66.22 per share, for a total transaction of $50,327.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.05% of the stock is currently owned by company insiders.
Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. raised its stake in Henry Schein by 6.8% in the fourth quarter. BlackRock Inc. now owns 13,083,067 shares of the company’s stock valued at $874,737,000 after purchasing an additional 830,255 shares in the last quarter. Alliancebernstein L.P. raised its stake in Henry Schein by 2.2% in the fourth quarter. Alliancebernstein L.P. now owns 2,855,386 shares of the company’s stock valued at $190,911,000 after purchasing an additional 60,216 shares in the last quarter. State of Wisconsin Investment Board raised its stake in Henry Schein by 1.0% in the fourth quarter. State of Wisconsin Investment Board now owns 1,689,542 shares of the company’s stock valued at $112,963,000 after purchasing an additional 17,058 shares in the last quarter. Swedbank purchased a new stake in Henry Schein in the fourth quarter valued at approximately $104,373,000. Finally, Norges Bank purchased a new stake in Henry Schein in the fourth quarter valued at approximately $92,675,000. Institutional investors own 94.73% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Recommended Story: How to identify percentage decliners
For more information about research offerings from Zacks Investment Research, visit Zacks.com